BioCentury | May 23, 2005
Company News

Inhibetex, Organic Soils.com Inc. deal

...Cancer company Inhibetex reverse merged with OSLC in a stock deal. Inhibetex shareholders will own about...
...be named Inhibiton Therapeutics Inc. Inhibiton is studying how PKC isozymes regulate brain cancer cells. Inhibetex Therapeutics Inc....
Items per page:
1 - 1 of 1
BioCentury | May 23, 2005
Company News

Inhibetex, Organic Soils.com Inc. deal

...Cancer company Inhibetex reverse merged with OSLC in a stock deal. Inhibetex shareholders will own about...
...be named Inhibiton Therapeutics Inc. Inhibiton is studying how PKC isozymes regulate brain cancer cells. Inhibetex Therapeutics Inc....
Items per page:
1 - 1 of 1